Diagnòstic i terapèutica en oncologia
Publicacions destacades
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Giné E; de la Cruz F; Jiménez Ubieto A; López Jimenez J; Martín García-Sancho A;(...)García Sanz R; Nadeu F; Beà S; Campo E; López-Guillermo A .Referència:Journal Of Clinical Oncology 2022.
-
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [<sup>18</sup>F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125
Glickman A; Paredes P; Carreras-Diéguez N; Niñerola-Baizán A; Gaba L;(...)Romero I; Fernández-Galán E; Carrasco JL; Gil-Ibáñez B; Torné A .Referència:European Radiology 2022.
-
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines
Canals J; Navarro A; Vila C; Canals JM; Díaz T;Acosta-Plasencia M; Cros-Font C; Han B; He Y; Monzó M .Referència:Journal Of Experimental & Clinical Cancer Research 2022.
-
Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery
Vollmer I; Sánchez-Izquierdo N; Martínez D; Sánchez-Lorente D; Casanueva-Eliceiry S;Boada M; Guirao Á; Romero-Zayas I; Vidal-Sicart S; Paredes P.Referència:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients
González de Aledo-Castillo JM; Casanueva-Eliceiry S; Soler-Perromat A; Fuster D; Pastor V;(...)Viñolas N; Reyes R; Vollmer I; Paredes P; Puig-Butillé JA .Referència:European Journal Of Nuclear Medicine And Molecular Imaging 2021.
-
Sentinel Lymph Node Biopsy in Breast Cancer with Tc-99m-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer
Vidal-Sicart, S; Rioja, ME; Prieto, A; Goni, E; Gomez, I;Albala, MD; Lumbreras, L; Leon, LF; Gomez, JR; Campos, F.Referència:Journal Of Nuclear Medicine 2021.
-
PET/CT Integrated With CT Colonography in Preoperative Obstructive Colorectal Cancer by Incomplete Optical Colonoscopy A Prospective Study
Sanchez-Izquierdo, Nuria; Pages, Mario; Mayoral, Maria; Rubello, Domenico; Colletti, Patrick M.;Campos, Francisco; Romero, Inmaculada; Casanueva, Sebastian; Fritsch, Andrea; Fuster, David;.Referència:Clinical Nuclear Medicine 2020.
-
Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma
Sánchez-Izquierdo N; Perlaza P; Pagès M; Buxó E; Rios J;(...)Mayoral M; Casanueva S; Fernández-Esparrach G; Ginés A; Fuster D.Referència:Clinical Nuclear Medicine 2020.
-
Diagnostic accuracy of imaging studies for initial staging of T2b-T4b melanoma patients
Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A;(...)Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S .Referència:Journal Of The American Academy Of Dermatology 2019.
-
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G;(...)Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D .Referència:Clinical Nuclear Medicine 2018.